A White Marubozu is a bullish candlestick pattern in technical analysis. It forms when the opening price is the lowest for the period and the closing price is the highest.Read More

An uptrend signal is generated when the RSI value crosses above 50 from below.Read More

Piper Serica’s Abhay Agarwal says India’s next market rally will be powered by high-growth sectors like pharma and autos, while low-growth FMCG and IT remain unattractive despite cheaper valuations. He expects a strong earnings revival next year but believes FPI inflows will return only after a US market correction. Small and midcaps will drive most...Read More

SAMCO Securities’ Apurva Sheth anticipates a liquidity-driven Nifty rally to 24,500-27,500 by 2026, fueled by low inflation, potential RBI rate cuts, and global stimulus. Robust domestic SIP flows and renewed investor optimism are expected to support this upside surprise, despite muted earnings.Read More

As of November 25, six Nifty500 stocks closed more than 1.5% above their VWAP levels, indicating improving intraday sentiment and strengthening buying interest. A close above VWAP often reflects that the stock traded mostly at lower levels throughout the day but ended with upward momentum.Read More

Indian stock market presents a dual reality. While Sensex and Nifty approach record highs, a significant number of BSE-listed stocks have seen sharp declines. Over 576 stocks are down by at least 30% from their peaks. This divergence is attributed to valuation excesses and concentrated investment flows into select large-cap companies.Read More

HCLTech shares will be watched after the company announced a strategic collaboration with AWS to accelerate digital transformation in the financial services sector. The partnership aims to modernise legacy systems, enhance customer experiences, and deploy AI-driven, industry-compliant solutions across banking, wealth, and insurance, strengthening long-standing ties between both companies.Read More

Zydus Lifesciences will be in focus on Wednesday after receiving final USFDA approval for its Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg strengths. The drug, a generic version of Calan SR, is used to treat high blood pressure. The approval strengthens Zydus’ US portfolio and supports its ongoing expansion in...Read More

4 stocks with a market cap that surged over Rs 10,000 crore, 5-year swing high at the closing on November 25.Read More

Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a listing premium. Shares may list higher than the issue price. Refunds and demat credits are scheduled for November 27. The company is set to list on November 28 on NSE and BSE. A positive...Read More